266 related articles for article (PubMed ID: 32798261)
1. The effect of saffron supplementation on some inflammatory and oxidative markers, leptin, adiponectin, and body composition in patients with nonalcoholic fatty liver disease: A double-blind randomized clinical trial.
Pour FK; Aryaeian N; Mokhtare M; Mirnasrollahi Parsa RS; Jannani L; Agah S; Fallah S; Moradi N
Phytother Res; 2020 Dec; 34(12):3367-3378. PubMed ID: 32798261
[TBL] [Abstract][Full Text] [Related]
2. Functions of Coenzyme Q10 Supplementation on Liver Enzymes, Markers of Systemic Inflammation, and Adipokines in Patients Affected by Nonalcoholic Fatty Liver Disease: A Double-Blind, Placebo-Controlled, Randomized Clinical Trial.
Farsi F; Mohammadshahi M; Alavinejad P; Rezazadeh A; Zarei M; Engali KA
J Am Coll Nutr; 2016; 35(4):346-53. PubMed ID: 26156412
[TBL] [Abstract][Full Text] [Related]
3. The effect of alpha-lipoic acid on inflammatory markers and body composition in obese patients with non-alcoholic fatty liver disease: A randomized, double-blind, placebo-controlled trial.
Hosseinpour-Arjmand S; Amirkhizi F; Ebrahimi-Mameghani M
J Clin Pharm Ther; 2019 Apr; 44(2):258-267. PubMed ID: 30585337
[TBL] [Abstract][Full Text] [Related]
4. Effect of Phytosomal Curcumin on Circulating Levels of Adiponectin and Leptin in Patients with Non-Alcoholic Fatty Liver Disease: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
Mirhafez SR; Farimani AR; Dehhabe M; Bidkhori M; Hariri M; Ghouchani BF; Abdollahi F
J Gastrointestin Liver Dis; 2019 Jun; 28():183-189. PubMed ID: 31204416
[TBL] [Abstract][Full Text] [Related]
5. Oral coenzyme Q10 supplementation in patients with nonalcoholic fatty liver disease: effects on serum vaspin, chemerin, pentraxin 3, insulin resistance and oxidative stress.
Farhangi MA; Alipour B; Jafarvand E; Khoshbaten M
Arch Med Res; 2014 Oct; 45(7):589-95. PubMed ID: 25450583
[TBL] [Abstract][Full Text] [Related]
6. The effect of total anthocyanin-base standardized (Cornus mas L.) fruit extract on liver function, tumor necrosis factor α, malondealdehyde, and adiponectin in patients with non-alcoholic fatty liver: a study protocol for a double-blind randomized clinical trial.
Sangsefidi ZS; Hosseinzadeh M; Ranjbar AM; Akhondi-Meybodi M; Fallahzadeh H; Mozaffari-Khosravi H
Nutr J; 2019 Jul; 18(1):39. PubMed ID: 31324181
[TBL] [Abstract][Full Text] [Related]
7. The effect of melatonin on treatment of patients with non-alcoholic fatty liver disease: a randomized double blind clinical trial.
Bahrami M; Cheraghpour M; Jafarirad S; Alavinejad P; Asadi F; Hekmatdoost A; Mohammadi M; Yari Z
Complement Ther Med; 2020 Aug; 52():102452. PubMed ID: 32951715
[TBL] [Abstract][Full Text] [Related]
8. The effects of saffron (Crocus sativus L.) in conjunction with concurrent training on body composition, glycaemic status, and inflammatory markers in obese men with type 2 diabetes mellitus: A randomized double-blind clinical trial.
Hooshmand Moghadam B; Rashidlamir A; Attarzadeh Hosseini SR; Gaeini AA; Kaviani M
Br J Clin Pharmacol; 2022 Jul; 88(7):3256-3271. PubMed ID: 35001410
[TBL] [Abstract][Full Text] [Related]
9. Oral α-lipoic acid supplementation in patients with non-alcoholic fatty liver disease: effects on adipokines and liver histology features.
Rahmanabadi A; Mahboob S; Amirkhizi F; Hosseinpour-Arjmand S; Ebrahimi-Mameghani M
Food Funct; 2019 Aug; 10(8):4941-4952. PubMed ID: 31343010
[TBL] [Abstract][Full Text] [Related]
10. Chromium picolinate balances the metabolic and clinical markers in nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled trial.
Kooshki F; Moradi F; Karimi A; Niazkar HR; Khoshbaten M; Maleki V; Pourghassem Gargari B
Eur J Gastroenterol Hepatol; 2021 Oct; 33(10):1298-1306. PubMed ID: 32804855
[TBL] [Abstract][Full Text] [Related]
11. An energy-restricted high-protein diet supplemented with β-cryptoxanthin alleviated oxidative stress and inflammation in nonalcoholic fatty liver disease: a randomized controlled trial.
Haidari F; Hojhabrimanesh A; Helli B; Seyedian SS; Ahmadi-Angali K
Nutr Res; 2020 Jan; 73():15-26. PubMed ID: 31841744
[TBL] [Abstract][Full Text] [Related]
12. Genistein supplementation improves insulin resistance and inflammatory state in non-alcoholic fatty liver patients: A randomized, controlled trial.
Amanat S; Eftekhari MH; Fararouei M; Bagheri Lankarani K; Massoumi SJ
Clin Nutr; 2018 Aug; 37(4):1210-1215. PubMed ID: 28647291
[TBL] [Abstract][Full Text] [Related]
13. Effects of Delta-tocotrienol Supplementation on Liver Enzymes, Inflammation, Oxidative stress and Hepatic Steatosis in Patients with Nonalcoholic Fatty Liver Disease.
Pervez MA; Khan DA; Ijaz A; Khan S
Turk J Gastroenterol; 2018 Mar; 29(2):170-176. PubMed ID: 29749323
[TBL] [Abstract][Full Text] [Related]
14. The effect of nigella sativa supplementation on cardiometabolic outcomes in patients with non-alcoholic fatty liver: A randomized double-blind, placebo-controlled trial.
Rashidmayvan M; Vandyousefi S; Barati M; Salamat S; Ghodrat S; Khorasanchi M; Jahan-Mihan A; Nattagh-Eshtivani E; Mohammadshahi M
Complement Ther Clin Pract; 2022 Aug; 48():101598. PubMed ID: 35567872
[TBL] [Abstract][Full Text] [Related]
15. Effects of saffron (Crocus sativus L.) supplementation on inflammatory biomarkers: A systematic review and meta-analysis.
Asbaghi O; Sadeghian M; Sadeghi O; Rigi S; Tan SC; Shokri A; Mousavi SM
Phytother Res; 2021 Jan; 35(1):20-32. PubMed ID: 32525606
[TBL] [Abstract][Full Text] [Related]
16. Inflammatory markers response to citrulline supplementation in patients with non-alcoholic fatty liver disease: a randomized, double blind, placebo-controlled, clinical trial.
Darabi Z; Darand M; Yari Z; Hedayati M; Faghihi A; Agah S; Hekmatdoost A
BMC Res Notes; 2019 Feb; 12(1):89. PubMed ID: 30767788
[TBL] [Abstract][Full Text] [Related]
17. Effect of green coffee extract supplementation on serum adiponectin concentration and lipid profile in patients with non-alcoholic fatty liver disease: A randomized, controlled trial.
Hosseinabadi S; Rafraf M; Asghari S; Asghari-Jafarabadi M; Vojouhi S
Complement Ther Med; 2020 Mar; 49():102290. PubMed ID: 32147076
[TBL] [Abstract][Full Text] [Related]
18. Glucose homeostasis, insulin resistance and inflammatory biomarkers in patients with non-alcoholic fatty liver disease: Beneficial effects of supplementation with microalgae Chlorella vulgaris: A double-blind placebo-controlled randomized clinical trial.
Ebrahimi-Mameghani M; Sadeghi Z; Abbasalizad Farhangi M; Vaghef-Mehrabany E; Aliashrafi S
Clin Nutr; 2017 Aug; 36(4):1001-1006. PubMed ID: 27475283
[TBL] [Abstract][Full Text] [Related]
19. Does vitamin D improve liver enzymes, oxidative stress, and inflammatory biomarkers in adults with non-alcoholic fatty liver disease? A randomized clinical trial.
Sharifi N; Amani R; Hajiani E; Cheraghian B
Endocrine; 2014 Sep; 47(1):70-80. PubMed ID: 24968737
[TBL] [Abstract][Full Text] [Related]
20. Delta-tocotrienol supplementation improves biochemical markers of hepatocellular injury and steatosis in patients with nonalcoholic fatty liver disease: A randomized, placebo-controlled trial.
Pervez MA; Khan DA; Slehria AUR; Ijaz A
Complement Ther Med; 2020 Aug; 52():102494. PubMed ID: 32951743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
